Clinicopathological study of a dimorphic variant of breast carcinoma
Explore this paper's citation graph
Summary
The typical morphological architecture of this carcinoma and expression of immunohistochemical markers support the diagnosis and the morphological features of dimorphic cells may be confused with cells of other origins if the features of the dimorphIC cells are not recognized.
- Type
- article
- Published
- 2017-09-30
- Cited by
- 3
- References
- 28
- Access
- Open access
- OpenAlex
- https://openalex.org/W2758524948
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:3588839
Keywords
Sexual dimorphism, Cytokeratin, Myoepithelial cell, Pathology, Biology
References
- Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes
- Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer.
- Androgen receptors frequently are expressed in breast carcinomas
- Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
- Rosen's Breast Pathology
- The clinical use of a P63/cytokeratin7/18/cytokeratin5/14 antibody cocktail in diagnostic breast pathology.
- Rosai and Ackerman???s Surgical Pathology
- Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
- Hormone Receptor Profile of Apocrine Lesions of the Breast
- Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast.
- Intraductal (intracystic) papillary carcinoma of the breast and its variants: a clinicopathological study of 77 cases.
- Papillary lesions of the breast—accuracy of core biopsy
- Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum
- Application of immunohistochemistry to breast lesions.
- Molecular portraits of human breast tumours
- Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
- Distribution of p63, a novel myoepithelial marker, in fine‐needle aspiration biopsies of the breast
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
- Genomic profile of a secretory breast cancer with an ETV6–NTRK3 duplication
Cited by
Related papers
- Phenotypic Alterations in Myoepithelial Cells Associated With Benign Sclerosing Lesions of the Breast
- The Expression of p63 and Cytokeratin 5 in Mixed Tumors of the Canine Mammary Gland Provides New Insights into the Histogenesis of These Neoplasms
- Monomorphic adenomas of the salivary glands. A clinico-pathologic study of 12 cases with immunohistochemical observation.
- The search for suitable prognostic markers for canine mammary tumors: A promising outlook.
- Immunohistochemical expression of myoepithelial markers in adenomyoepithelioma of the breast: a unique paradoxical staining pattern of high-molecular weight cytokeratins
- Expression and prognostic significance of CK19 in canine malignant mammary tumours.
- Histopathological and immunohistochemical features of atypical epithelial tumours of the gland of the third eyelid in seven dogs.
- Tissue heterogeneity of immunohistochemically detected estrogen receptor. Implications for image analysis quantification.